Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Edward G Spack. (1997) Antigen-specific therapies for the treatment of multiple sclerosis: a clinical trial update. Expert Opinion on Investigational Drugs 6:11, pages 1715-1727.
Read now
Read now
Stephen Donoghue. (1996) Clinical Trials Report Central & Peripheral Nervous Systems: Drugs in development for the treatment of multiple sclerosis: antigen non-specific therapies. Expert Opinion on Investigational Drugs 5:10, pages 1349-1357.
Read now
Read now
Articles from other publishers (3)
B. Mazzanti, B. Hemmer, E. Traggiai, C. Ballerini, H.F. McFarland, L. Massacesi, R. Martin & M. Vergelli. (2000) Decrypting the spectrum of antigen-specific T-cell responses: the avidity repertoire of MBP-specific T-cells. Journal of Neuroscience Research 59:1, pages 86-93.
Crossref
Crossref
Edward G. Spack, Nancy G. Wehner & Jeffrey L. Winkelhake. (2006) Preclinical and Pharmacological Studies of AG284, a Soluble HLA‐DR2:Myelin Basic Protein Peptide Complex for the Treatment of Multiple Sclerosis. CNS Drug Reviews 4:3, pages 225-246.
Crossref
Crossref
Alison P Bond, Louise Corlett, S.John Curnow, Edward Spack, Nick Willcox & John Newsom-Davis. (1998) Diverse patterns of unresponsiveness in an acetylcholine receptor-specific T-cell clone from a myasthenia gravis patient after engaging the T-cell receptor with three different ligands. Journal of Neuroimmunology 82:2, pages 182-190.
Crossref
Crossref